Synergistic combination of histone deacetylase inhibitor suberoylanilide hydroxamic acid and oncolytic adenovirus ZD55-TRAIL as a therapy against cervical cancer
Xiujun Han(Women's Hospital, School of Medicine, Zhejiang University), Weiguo Lv(Women's Hospital, School of Medicine, Zhejiang University)
Cited by 11
Related Papers
HPV16 E6-Activated OCT4 Promotes Cervical Cancer Progression by Suppressing p53 Expression via Co-Repressor NCOR1
|Frontiers in Oncology|2022|25